APA (7th ed.) Citation

S, M., 3rd, A. B., C, B., ER, B., HA, Y., JS, R., . . . WB, D. (2024). A phase 3b study of venetoclax and azacitidine or decitabine in an outpatient setting in patients with acute myeloid leukemia. Hematological oncology, 42(3), e3274. https://doi.org/10.1002/hon.3274

Chicago Style (17th ed.) Citation

S, Manda, et al. "A Phase 3b Study of Venetoclax and Azacitidine or Decitabine in an Outpatient Setting in Patients with Acute Myeloid Leukemia." Hematological Oncology 42, no. 3 (2024): e3274. https://doi.org/10.1002/hon.3274.

MLA (9th ed.) Citation

S, Manda, et al. "A Phase 3b Study of Venetoclax and Azacitidine or Decitabine in an Outpatient Setting in Patients with Acute Myeloid Leukemia." Hematological Oncology, vol. 42, no. 3, 2024, p. e3274, https://doi.org/10.1002/hon.3274.